Skip to main content

Multisystem Inflammatory Syndrome in Adults clinical trials at University of California Health

3 in progress, 1 open to eligible people

Showing trials for
  • Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

    open to eligible people ages 0-20

    The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The…

    at UCLA

  • MIS-C Comparative Effectiveness Study

    Sorry, in progress, not accepting new patients

    In March 2020, children exposed to the virus that causes the COVID-19 illness, SARS-CoV-2, presented with fever and significant inflammation about a month after exposure to the virus. Some children were sick enough to require care in the intensive…

    at UCSD

  • Long-Term Outcomes After the Multisystem Inflammatory Syndrome in Children

    Sorry, in progress, not accepting new patients

    Multi-system Inflammatory Syndrome in Children (MIS-C) is a new condition related to COVID-19, the study investigators are still learning about its causes, effects, and long-term impact. "Long-Term Outcomes after the Multisystem Inflammatory…

    at UCSD

Our lead scientists for Multisystem Inflammatory Syndrome in Adults research studies include .

Last updated: